SALL4 oncogene is an immunogenic antigen presented in various HLA-DR contexts

Purpose: To investigate the immunoprevalence of SALL4-derived peptides in healthy volunteers and cancer patients. Experimental Design: A multistep approach including prediction algorithms was used to design in silico SALL4-derived peptides theoretically able to bind on common HLA-DR and HLA-A/B mole...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Oncoimmunology
Prif Awduron: Kroemer, Marie, Spehner, Laurie, Mercier-Letondal, Patricia, Boullerot, Laura, Kim, Stefano, Jary, Marine, Galaine, Jeanne, Picard, Emilie, Ferrand, Christophe, Nguyen, Thierry, Larosa, Fabrice, Adotévi, Olivier, Godet, Yann, Borg, Christophe
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Taylor & Francis 2018
Pynciau:
Original Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5889287/
https://ncbi.nlm.nih.gov/pubmed/29632725
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2017.1412030
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg